-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Cytek Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q2 2020 to Q3 2025.
- Cytek Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $5.64M, a 20.1% decline year-over-year.
- Cytek Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $26.1M, a 2.15% increase year-over-year.
- Cytek Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $26.8M, a 21.8% increase from 2023.
- Cytek Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $22M, a 32.9% increase from 2022.
- Cytek Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $16.6M, a 152% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)